Nicorandil Marke Size, Share and Trends Report 2025 to 2034
Segmentation of Nicorandil Market -
Nicorandil Market by Dosage Form-
• Oral Solutions
• Tablets
• Injectables
• Extended-Release Formulations
Nicorandil Market by Therapeutic Application -
• Hypertension
• Ischemic Heart Disease
• Heart Failure
• Chronic Stable Angina
Nicorandil Market by Patient Demographics-
• Pediatric Patients
• Young Adults (18-44 Years)
• Middle-Aged (45-64 Years)
• Aged (65+ Years)
Nicorandil Market by End User-
• Healthcare Professionals
o Doctors
o Cardiologists
• Pharmacists
• Patients
• Healthcare Institutions
Nicorandil Market by Distribution Channel-
• Hospitals and Clinics
• Retail Pharmacies
• Specialty Pharmacies
• Online Pharmacies
Nicorandil Market by Region-
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Nicorandil Market Snapshot
Chapter 4. Global Nicorandil Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2025-2034
4.8. Competitive Landscape & Market Share Analysis, By Key Player (2024)
4.9. Use/impact of AI on Nicorandil Market Industry Trends
4.10. Global Nicorandil Market Penetration & Growth Prospect Mapping (US$ Mn), 2024-2034
Chapter 5. Nicorandil Market Segmentation 1: By Therapeutic Application, Estimates & Trend Analysis
5.1. Market Share by Therapeutic Application, 2024 & 2034
5.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Therapeutic Application:
5.2.1. Ischemic Heart Disease
5.2.2. Chronic Stable Angina
5.2.3. Heart Failure
5.2.4. Hypertension
Chapter 6. Nicorandil Market Segmentation 2: By End-User, Estimates & Trend Analysis
6.1. Market Share by End-User, 2024 & 2034
6.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User:
6.2.1. Tablets
6.2.2. Oral Solutions
6.2.3. Extended-Release Formulations
6.2.4. Injectables
Chapter 7. Nicorandil Market Segmentation 3: By Application, Estimates & Trend Analysis
7.1. Market Share by Application, 2024 & 2034
7.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
7.2.1. Orthopedics
7.2.2. Pediatrics
7.2.3. Rehabilitation
7.2.4. Sports Medicine
Chapter 8. Nicorandil Market Segmentation 4: By Patient Demographics, Estimates & Trend Analysis
8.1. Market Share by Patient Demographics, 2024 & 2034
8.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Patient Demographics:
8.2.1. Aged (65+ years)
8.2.2. Middle-Aged (45-64 years)
8.2.3. Young Adults (18-44 years)
8.2.4. Pediatric Patients
Chapter 9. Nicorandil Market Segmentation 5: By Distribution Channel, Estimates & Trend Analysis
9.1. Market Share by Distribution Channel, 2024 & 2034
9.2. Market Size Revenue (US$ Million) & Forecasts and Trend Analyses, 2021 to 2034 for the following Distribution Channel:
9.2.1. Hospitals and Clinics
9.2.2. Retail Pharmacies
9.2.3. Online Pharmacies
9.2.4. Specialty Pharmacies
Chapter 10. Nicorandil Market Segmentation 6: Regional Estimates & Trend Analysis
10.1. Global Nicorandil Market, Regional Snapshot 2024 & 2034
10.2. North America
10.2.1. North America Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.2.1.1. US
10.2.1.2. Canada
10.2.2. North America Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Application, 2021-2034
10.2.3. North America Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.2.4. North America Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.2.5. North America Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021-2034
10.2.6. North America Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Patient Demographics, 2021-2034
10.2.7. North America Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
10.3. Europe
10.3.1. Europe Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.3.1.1. Germany
10.3.1.2. U.K.
10.3.1.3. France
10.3.1.4. Italy
10.3.1.5. Spain
10.3.1.6. Rest of Europe
10.3.2. Europe Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Application, 2021-2034
10.3.3. Europe Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.3.4. Europe Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.3.5. Europe Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Patient Demographics, 2021-2034
10.3.6. Europe Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
10.4. Asia Pacific
10.4.1. Asia Pacific Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.4.1.1. India
10.4.1.2. China
10.4.1.3. Japan
10.4.1.4. Australia
10.4.1.5. South Korea
10.4.1.6. Hong Kong
10.4.1.7. Southeast Asia
10.4.1.8. Rest of Asia Pacific
10.4.2. Asia Pacific Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Application, 2021-2034
10.4.3. Asia Pacific Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.4.4. Asia Pacific Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.4.5. Asia Pacific Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Patient Demographics, 2021-2034
10.4.6. Asia Pacific Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
10.5. Latin America
10.5.1. Latin America Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034
10.5.1.1. Brazil
10.5.1.2. Mexico
10.5.1.3. Rest of Latin America
10.5.2. Latin America Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Application, 2021-2034
10.5.3. Latin America Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.5.4. Latin America Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.5.5. Latin America Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Patient Demographics, 2021-2034
10.5.6. Latin America Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
10.6. Middle East & Africa
10.6.1. Middle East & Africa Wind Turbine Rotor Blade Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
10.6.1.1. GCC Countries
10.6.1.2. Israel
10.6.1.3. South Africa
10.6.1.4. Rest of Middle East and Africa
10.6.2. Middle East & Africa Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Application, 2021-2034
10.6.3. Middle East & Africa Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
10.6.4. Middle East & Africa Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Application, 2021-2034
10.6.5. Middle East & Africa Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Patient Demographics, 2021-2034
10.6.6. Middle East & Africa Nicorandil Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2021-2034
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Shanghai Yuanye Bio-Technology Co.
11.2.1.1. Business Overview
11.2.1.2. Key Patient Demographics /Service Overview
11.2.1.3. Financial Performance
11.2.1.4. Geographical Presence
11.2.1.5. Recent Developments with Business Strategy
11.2.2. Merck
11.2.3. Shanghai Myrell Chemical Technology Co.
11.2.4. J&K Scientific
11.2.5. Shanghai Aladdin Biochemical Technology Co.
11.2.6. Shenzhen Feisi Biological Technology Co.
11.2.7. Yunnan Xili Biotechnology Co. LTD
11.2.8. Nanjing Shenglide Biotechnology Co.
11.2.9. Nanjing Luomeimei Biotechnology Co.
11.2.10. AdooQ BioScience
11.2.11. Wuhan Belka Biomedicine
11.2.12. Biorbyt
11.2.13. Biosynth Carbosynth
11.2.14. ApexBio Technology
11.2.15. Cayman Chemical
11.2.16. TCI
11.2.17. Targetmol
11.2.18. QCC
11.2.19. A&A Life Science Inc
11.2.20. Santa Cruz Biotechnology
11.2.21. Combi-Blocks Inc
11.2.22. Alfa Chemistry
11.2.23. Toronto Research Chemicals Inc
11.2.24. Apollo Scientific Ltd
11.2.25. 3B Scientific
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Nicorandil Market Size is predicted to grow at an 8.5% CAGR over the forecast period.
The major players in the Nicorandil market are Nanjing Luomeimei Biotechnology Co. LTD, Merck, Shanghai Myrell Chemical Technology Co. LTD, Shanghai Yuanye Bio-Technology Co. Ltd, J&K Scientific, Shenzhen Feisi Biological Technology Co. LTD, Yunnan Xili Biotechnology Co. LTD, Shanghai Aladdin Biochemical Technology Co. LTD, Nanjing Shenglide Biotechnology Co. LTD, Biorbyt, Biosynth Carbosynth, ApexBio Technology, Santa Cruz BiotechnologyInc., Combi-Blocks Inc, AdooQ BioScience, Wuhan Belka Biomedicine, Alfa Chemistry, Toronto Research Chemicals Inc, Apollo Scientific Ltd, 3B Scientific, Carbone Scientific, Cayman Chemical, TCI, Targetmol, QCC, and A&A Life Science Inc.
The primary Nicorandil market segments are Dosage Form, Therapeutic Application, Patient Demographics, End User, and Distribution Channel.
North America leads the market for Nicorandil driven by the frequency of cardiovascular diseases, the development of cutting-edge cardiac drugs, and sophisticated healthcare infrastructure.